Literature DB >> 21590710

The role of Lrp5/6 in cardiac valve disease: LDL-density-pressure theory.

Nalini M Rajamannan1.   

Abstract

Atherosclerosis and osteoporosis are the leading causes of mortality and morbidity in the World. Recent epidemiologic studies have demonstrated that these disease processes develop in parallel. Evidence indicates that hyperlipidemia plays a paradoxical role in both disease processes. However, the mechanism is not understood. This prospectus hypothesizes the role of lipids activate atherosclerosis within the bone and the heart to initiate the development of diseases in both of these tissues. The Prospectus on the Lrp 5/6 receptors provides a foundation for the mechanisms involved in the Lrp5/6 mediated disease biology. The LDL-Density-Pressure theory: the Role of Lrp5/6 provides a biological and a hemodynamic approach towards understanding the development of valvular heart disease and the implications in the field of bone molecular biology. This prospectus will review the current literature, provide a basis for the development of valve disease and indicate future therapeutic pathways for this disease process in the future.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21590710      PMCID: PMC3927739          DOI: 10.1002/jcb.23182

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  65 in total

1.  Atorvastatin decreases cellular proliferation and bone matrix expression in the hypercholesterolemic mitral valve.

Authors:  Babu Makkena; Hani Salti; Malayannan Subramaniam; Senthil Thennapan; Robert H Bonow; Frank Caira; Robert O Bonow; Thomas C Spelsberg; Nalini M Rajamannan
Journal:  J Am Coll Cardiol       Date:  2005-02-15       Impact factor: 24.094

2.  Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals.

Authors:  Jian-Su Shao; Su-Li Cheng; Joyce M Pingsterhaus; Nichole Charlton-Kachigian; Arleen P Loewy; Dwight A Towler
Journal:  J Clin Invest       Date:  2005-04-14       Impact factor: 14.808

3.  A case-control investigation of the relation between hyperlipidaemia and calcific aortic valve stenosis.

Authors:  P T Wilmshurst; R N Stevenson; H Griffiths; J R Lord
Journal:  Heart       Date:  1997-11       Impact factor: 5.994

4.  Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly.

Authors:  C M Otto; B K Lind; D W Kitzman; B J Gersh; D S Siscovick
Journal:  N Engl J Med       Date:  1999-07-15       Impact factor: 91.245

5.  Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6.

Authors:  Sheri L Holmen; Troy A Giambernardi; Cassandra R Zylstra; Bree D Buckner-Berghuis; James H Resau; J Fred Hess; Vaida Glatt; Mary L Bouxsein; Minrong Ai; Matthew L Warman; Bart O Williams
Journal:  J Bone Miner Res       Date:  2004-09-13       Impact factor: 6.741

6.  Apparently normal mitral valves in patients with heart failure demonstrate biochemical and structural derangements: an extracellular matrix and echocardiographic study.

Authors:  K Jane Grande-Allen; Allen G Borowski; Richard W Troughton; Penny L Houghtaling; Nicholas R Dipaola; Christine S Moravec; Ivan Vesely; Brian P Griffin
Journal:  J Am Coll Cardiol       Date:  2005-01-04       Impact factor: 24.094

7.  Cloning of a novel member of the low-density lipoprotein receptor family.

Authors:  P J Hey; R C Twells; M S Phillips; S D Brown; Y Kawaguchi; R Cox; V Dugan; H Hammond; M L Metzker; J A Todd; J F Hess
Journal:  Gene       Date:  1998-08-17       Impact factor: 3.688

8.  Molecular cloning and characterization of LR3, a novel LDL receptor family protein with mitogenic activity.

Authors:  Y Dong; W Lathrop; D Weaver; Q Qiu; J Cini; D Bertolini; D Chen
Journal:  Biochem Biophys Res Commun       Date:  1998-10-29       Impact factor: 3.575

9.  Isolation and characterization of LRP6, a novel member of the low density lipoprotein receptor gene family.

Authors:  S D Brown; R C Twells; P J Hey; R D Cox; E R Levy; A R Soderman; M L Metzker; C T Caskey; J A Todd; J F Hess
Journal:  Biochem Biophys Res Commun       Date:  1998-07-30       Impact factor: 3.575

10.  A new low density lipoprotein receptor related protein, LRP5, is expressed in hepatocytes and adrenal cortex, and recognizes apolipoprotein E.

Authors:  D H Kim; Y Inagaki; T Suzuki; R X Ioka; S Z Yoshioka; K Magoori; M J Kang; Y Cho; A Z Nakano; Q Liu; T Fujino; H Suzuki; H Sasano; T T Yamamoto
Journal:  J Biochem       Date:  1998-12-01       Impact factor: 3.387

View more
  15 in total

1.  The role of Lrp5/6 in cardiac valve disease: experimental hypercholesterolemia in the ApoE-/- /Lrp5-/- mice.

Authors:  Nalini M Rajamannan
Journal:  J Cell Biochem       Date:  2011-10       Impact factor: 4.429

Review 2.  Targeting Wnt-Frizzled signaling in cardiovascular diseases.

Authors:  Saumya Pandey
Journal:  Mol Biol Rep       Date:  2013-09-21       Impact factor: 2.316

3.  Transglutaminase 2-mediated activation of β-catenin signaling has a critical role in warfarin-induced vascular calcification.

Authors:  Kelly E Beazley; Stephanie Deasey; Florence Lima; Maria V Nurminskaya
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-10-27       Impact factor: 8.311

Review 4.  From skeletal to cardiovascular disease in 12 steps-the evolution of sclerostin as a major player in CKD-MBD.

Authors:  Vincent M Brandenburg; Patrick D'Haese; Annika Deck; Djalila Mekahli; Björn Meijers; Ellen Neven; Pieter Evenepoel
Journal:  Pediatr Nephrol       Date:  2015-03-04       Impact factor: 3.714

5.  Quercetin attenuates warfarin-induced vascular calcification in vitro independently from matrix Gla protein.

Authors:  Kelly E Beazley; Saman Eghtesad; Maria V Nurminskaya
Journal:  J Biol Chem       Date:  2012-12-07       Impact factor: 5.157

Review 6.  LRP5 and LRP6 in development and disease.

Authors:  Danese M Joiner; Jiyuan Ke; Zhendong Zhong; H Eric Xu; Bart O Williams
Journal:  Trends Endocrinol Metab       Date:  2013-01       Impact factor: 12.015

Review 7.  Myxomatous mitral valve disease bench to bedside: LDL-density-pressure regulates Lrp5.

Authors:  Nalini M Rajamannan
Journal:  Expert Rev Cardiovasc Ther       Date:  2014-03

8.  Simulation of early calcific aortic valve disease in a 3D platform: A role for myofibroblast differentiation.

Authors:  Jesper Hjortnaes; Claudia Goettsch; Joshua D Hutcheson; Gulden Camci-Unal; Lilian Lax; Katrin Scherer; Simon Body; Frederick J Schoen; Jolanda Kluin; Ali Khademhosseini; Elena Aikawa
Journal:  J Mol Cell Cardiol       Date:  2016-03-17       Impact factor: 5.000

Review 9.  WNT Signaling in Cardiac and Vascular Disease.

Authors:  Sébastien Foulquier; Evangelos P Daskalopoulos; Gentian Lluri; Kevin C M Hermans; Arjun Deb; W Matthijs Blankesteijn
Journal:  Pharmacol Rev       Date:  2018-01       Impact factor: 25.468

10.  Bioreactor Conditioning of Valve Scaffolds Seeded Internally with Adult Stem Cells.

Authors:  Allison Kennamer; Leslie Sierad; Richard Pascal; Nicholas Rierson; Christopher Albers; Marius Harpa; Ovidiu Cotoi; Lucian Harceaga; Peter Olah; Preda Terezia; Agneta Simionescu; Dan Simionescu
Journal:  Tissue Eng Regen Med       Date:  2016-10-20       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.